TY - JOUR AU - Lennernas, H. PY - 2003 DA - 2003// TI - Clinical pharmacokinetics of atorvastatin JO - Clin Pharmacokinet VL - 42 UR - https://doi.org/10.2165/00003088-200342130-00005 DO - 10.2165/00003088-200342130-00005 ID - Lennernas2003 ER - TY - STD TI - Kivisto KT, Niemi M, Schaeffeler E, Pitkala K, Tilvis R, Fromm MF, et al. Lipid-lowering response to statins is affected by CYP3A5 polymorphism. Pharmacogenetics. 2004;14(8):523–5. doi:00008571-200408000-00005. ID - ref2 ER - TY - JOUR AU - Ahmed, T. AU - Kollipara, S. AU - Gautam, A. AU - Gigras, R. AU - Kothari, M. AU - Saha, N. PY - 2009 DA - 2009// TI - Bioavailability and Interaction Potential of Atorvastatin and Losartan on Coadministration in Healthy Human Subjects JO - J Bioequivalence Bioavailability VL - 1 ID - Ahmed2009 ER - TY - JOUR AU - Jacobsen, W. AU - Kuhn, B. AU - Soldner, A. AU - Kirchner, G. AU - Sewing, K. F. AU - Kollman, P. A. PY - 2000 DA - 2000// TI - Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin JO - Drug Metab Dispos VL - 28 ID - Jacobsen2000 ER - TY - JOUR AU - Riedmaier, S. AU - Klein, K. AU - Hofmann, U. AU - Keskitalo, J. E. AU - Neuvonen, P. J. AU - Schwab, M. PY - 2010 DA - 2010// TI - UDP-glucuronosyltransferase (UGT) polymorphisms affect atorvastatin lactonization in vitro and in vivo JO - Clin Pharmacol Ther VL - 87 UR - https://doi.org/10.1038/clpt.2009.181 DO - 10.1038/clpt.2009.181 ID - Riedmaier2010 ER - TY - JOUR AU - Chen, C. AU - Mireles, R. J. AU - Campbell, S. D. AU - Lin, J. AU - Mills, J. B. AU - Xu, J. J. PY - 2005 DA - 2005// TI - Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1 JO - Drug Metab Dispos VL - 33 UR - https://doi.org/10.1124/dmd.104.002477 DO - 10.1124/dmd.104.002477 ID - Chen2005 ER - TY - STD TI - Romaine SP, Bailey KM, Hall AS, Balmforth AJ. The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy. Pharmacogenomics J. 2010;10(1):1–11. doi:10.1038/tpj.2009.54tpj200954. ID - ref7 ER - TY - JOUR AU - Schwarz, U. I. PY - 2011 DA - 2011// TI - Meyer zu Schwabedissen HE, Tirona RG, Suzuki A, Leake BF, Mokrab Y et al. Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity JO - Pharmacogenet Genomics VL - 21 UR - https://doi.org/10.1097/FPC.0b013e328342f5b1 DO - 10.1097/FPC.0b013e328342f5b1 ID - Schwarz2011 ER - TY - JOUR AU - Keskitalo, J. E. AU - Zolk, O. AU - Fromm, M. F. AU - Kurkinen, K. J. AU - Neuvonen, P. J. AU - Niemi, M. PY - 2009 DA - 2009// TI - ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin JO - Clin Pharmacol Ther VL - 86 UR - https://doi.org/10.1038/clpt.2009.79 DO - 10.1038/clpt.2009.79 ID - Keskitalo2009 ER - TY - STD TI - Mangravite LM, Thorn CF, Krauss RM. Clinical implications of pharmacogenomics of statin treatment. Pharmacogenomics J. 2006;6(6):360–74. doi:10.1038/sj.tpj.6500384.6500384. ID - ref10 ER - TY - STD TI - U.S. Food and Drug Administration. Guidance for Industry Clinical Pharmacogenomics: Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling.Silver Spring: U.S. Department of Health and Human Services; 2013. ID - ref11 ER - TY - JOUR AU - Leon-Cachon, R. B. AU - Ascacio-Martinez, J. A. AU - Barrera-Saldana, H. A. PY - 2012 DA - 2012// TI - Individual response to drug therapy: bases and study approaches JO - Rev Invest Clin VL - 64 ID - Leon-Cachon2012 ER - TY - BOOK PY - 2014 DA - 2014// TI - Draft Guidance on Atorvastatin Calcium and Ezetimibe PB - U.S. Department of Health and Human Services CY - Silver Spring ID - ref13 ER - TY - JOUR AU - Gandelman, K. AU - Malhotra, B. AU - LaBadle, R. AU - Crownover, P. AU - Bergstrom, T. PY - 2011 DA - 2011// TI - Analytes of Interest and Choice of Dose: Two Important Considerations in the Design of Bioequivalence Studies with Atorvastatin JO - J Bioequiv Availab VL - 3 UR - https://doi.org/10.4172/jbb.1000060 DO - 10.4172/jbb.1000060 ID - Gandelman2011 ER - TY - STD TI - Cavallari L, Lam Y. Pharmacogenetics. In: DiPiro J, Talbert R, Yee G, Matzke G, Wells B, Posey L, eds. Pharmacotherapy: A Pathophysiologic Approach. 9a ed. New York, NY: McGraw-Hill; 2014. p. 2559. ID - ref15 ER - TY - JOUR AU - Rosales, A. AU - Alvear, M. AU - Cuevas, A. AU - Saavedra, N. AU - Zambrano, T. AU - Salazar, L. A. PY - 2012 DA - 2012// TI - Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia JO - Clin Chim Acta Intl J Clin Chem VL - 413 UR - https://doi.org/10.1016/j.cca.2011.11.003 DO - 10.1016/j.cca.2011.11.003 ID - Rosales2012 ER - TY - JOUR AU - Eichelbaum, M. AU - Ingelman-Sundberg, M. AU - Evans, W. E. PY - 2006 DA - 2006// TI - Pharmacogenomics and individualized drug therapy JO - Annu Rev Med VL - 57 UR - https://doi.org/10.1146/annurev.med.56.082103.104724 DO - 10.1146/annurev.med.56.082103.104724 ID - Eichelbaum2006 ER - TY - STD TI - Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467(7319):1061–73. doi:10.1038/nature09534. nature09534. ID - ref18 ER - TY - JOUR AU - Madsen, B. E. AU - Villesen, P. AU - Wiuf, C. PY - 2010 DA - 2010// TI - Short tandem repeats and genetic variation JO - Methods Mol Biol VL - 628 UR - https://doi.org/10.1007/978-1-60327-367-1_16 DO - 10.1007/978-1-60327-367-1_16 ID - Madsen2010 ER - TY - STD TI - Pang AW, MacDonald JR, Pinto D, Wei J, Rafiq MA, Conrad DF, et al. Towards a comprehensive structural variation map of an individual human genome. Genome Biol. 2010;11(5):R52. doi:10.1186/gb-2010-11-5-r52.gb-2010-11-5-r52. ID - ref20 ER - TY - STD TI - Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet. 2005;6(2):95–108. doi:10.1038/nrg1521. nrg1521. ID - ref21 ER - TY - STD TI - Solorzano-Flores LI. NORMA Oficial Mexicana NOM-177-SSA1-1998, Que establece las pruebas y procedimientos para demostrar que un medicamento es intercambiable. Requisitos a que deben sujetarse los terceros autorizados que realicen las pruebas. Secretaría de Salud, México, DF. 1999. http://www.salud.gob.mx/unidades/cdi/nom/177ssa18.html. 2010. UR - http://www.salud.gob.mx/unidades/cdi/nom/177ssa18.html ID - ref22 ER - TY - JOUR AU - Ma, L. AU - Dong, J. AU - Chen, X. AU - Wang, G. PY - 2007 DA - 2007// TI - Development and validation of atorvastatin by LC–ESI–MS and application in bioequivalence research in healthy Chinese volunteers JO - Chromatographia VL - 65 UR - https://doi.org/10.1365/s10337-007-0236-4 DO - 10.1365/s10337-007-0236-4 ID - Ma2007 ER - TY - JOUR AU - Stanisz, B. AU - Kania, L. PY - 2006 DA - 2006// TI - Validation of HPLC method for determination of atorvastatin in tablets and for monitoring stability in solid phase JO - Acta Pol Pharm VL - 63 ID - Stanisz2006 ER - TY - BOOK AU - Sambrook, J. PY - 2001 DA - 2001// TI - Russell D W. Preparation and Analysis of Eukaryotic Genomic DNA. Molecular cloning: a laboratory manual. Third ed PB - Cold Spring Harbor Laboratory Press CY - Cold Spring Harbor ID - Sambrook2001 ER - TY - JOUR AU - Tejedor, D. AU - Castillo, S. AU - Mozas, P. AU - Jimenez, E. AU - Lopez, M. AU - Tejedor, M. T. PY - 2005 DA - 2005// TI - Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia JO - Clin Chem VL - 51 UR - https://doi.org/10.1373/clinchem.2004.045203 DO - 10.1373/clinchem.2004.045203 ID - Tejedor2005 ER - TY - JOUR AU - Miyaji, K. AU - Nagao, K. AU - Bannai, M. AU - Asakawa, H. AU - Kohyama, K. AU - Ohtsu, D. PY - 2010 DA - 2010// TI - Characteristic metabolism of free amino acids in cetacean plasma: cluster analysis and comparison with mice JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0013808 DO - 10.1371/journal.pone.0013808 ID - Miyaji2010 ER - TY - JOUR AU - Reed, T. E. AU - Schull, W. J. PY - 1968 DA - 1968// TI - A general maximum likelihood estimation program JO - Am J Hum Genet VL - 20 ID - Reed1968 ER - TY - JOUR AU - Benjamini, Y. AU - Hochberg, Y. PY - 1995 DA - 1995// TI - Controlling the false discovery rate: a practical and powerful approach to multiple testing JO - J R Stat Soc Ser B Methodol VL - 57 ID - Benjamini1995 ER - TY - JOUR AU - Endrenyi, L. AU - Fritsch, S. AU - Yan, W. PY - 1991 DA - 1991// TI - Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence JO - Int J Clin Pharmacol Ther Toxicol VL - 29 ID - Endrenyi1991 ER - TY - JOUR AU - Burim, R. V. AU - Canalle, R. AU - Martinelli Ade, L. AU - Takahashi, C. S. PY - 2004 DA - 2004// TI - Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics JO - Mutagenesis VL - 19 UR - https://doi.org/10.1093/mutage/geh034 DO - 10.1093/mutage/geh034 ID - Burim2004 ER - TY - STD TI - Huang Q, Aa J, Jia H, Xin X, Tao C, Liu L et al. A Pharmacometabonomic Approach to Predicting Metabolic Phenotypes and Pharmacokinetic Parameters of Atorvastatin in Healthy Volunteers. Journal of proteome research. 2015. doi:10.1021/acs.jproteome.5b00440. ID - ref32 ER - TY - JOUR AU - Maitland-van der Zee, A. -. H. AU - Lynch, A. AU - Boerwinkle, E. AU - Arnett, D. K. AU - Davis, B. R. AU - Leiendecker-Foster, C. PY - 2008 DA - 2008// TI - Interactions between the SNPs in the homocysteine pathway (MTHFR 677C > T, MTHFR 1298 A > C and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk hypertensives: The GenHAT Study JO - Pharmacogenet Genomics VL - 18 UR - https://doi.org/10.1097/FPC.0b013e3282fe1759 DO - 10.1097/FPC.0b013e3282fe1759 ID - Maitland-van der Zee2008 ER - TY - JOUR AU - Izmirli, M. AU - Bacaksiz, A. AU - Alptekin, D. AU - Uysal, O. AU - Kilic, U. PY - 2014 DA - 2014// TI - Statin and MTHFR C677T Polymorphism in Patients with Cardiovascular Diseases JO - Bezmialem Sci VL - 2014 UR - https://doi.org/10.14235/bs.2014.311 DO - 10.14235/bs.2014.311 ID - Izmirli2014 ER - TY - JOUR AU - Savitz, J. AU - Hodgkinson, C. A. AU - Martin-Soelch, C. AU - Shen, P. H. AU - Szczepanik, J. AU - Nugent, A. PY - 2013 DA - 2013// TI - The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movement JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0054108 DO - 10.1371/journal.pone.0054108 ID - Savitz2013 ER - TY - JOUR AU - Kang, S. G. AU - Lee, B. H. AU - Lee, J. S. AU - Chai, Y. G. AU - Ko, K. P. AU - Lee, H. J. PY - 2014 DA - 2014// TI - DRD3 gene rs6280 polymorphism may be associated with alcohol dependence overall and with Lesch type I alcohol dependence in Koreans JO - Neuropsychobiology VL - 69 UR - https://doi.org/10.1159/000358062 DO - 10.1159/000358062 ID - Kang2014 ER - TY - JOUR AU - Kuo, S. C. AU - Yeh, Y. W. AU - Chen, C. Y. AU - Huang, C. C. AU - Chang, H. A. AU - Yen, C. H. PY - 2014 DA - 2014// TI - DRD3 variation associates with early-onset heroin dependence, but not specific personality traits JO - Prog Neuropsychopharmacol Biol Psychiatry VL - 51 UR - https://doi.org/10.1016/j.pnpbp.2013.12.018 DO - 10.1016/j.pnpbp.2013.12.018 ID - Kuo2014 ER - TY - JOUR AU - Jimenez-Jimenez, F. J. AU - Alonso-Navarro, H. AU - Martinez, C. AU - Zurdo, M. AU - Turpin-Fenoll, L. AU - Millan, J. PY - 2013 DA - 2013// TI - Dopamine receptor D3 (DRD3) gene rs6280 variant and risk for restless legs syndrome JO - Sleep Med VL - 14 UR - https://doi.org/10.1016/j.sleep.2012.11.009 DO - 10.1016/j.sleep.2012.11.009 ID - Jimenez-Jimenez2013 ER - TY - JOUR AU - Lopez Aspiroz, E. AU - Cabrera Figueroa, S. E. AU - Porras Hurtado, G. L. AU - Cruz Guerrero, R. AU - Dominguez-Gil Hurle, A. AU - Carracedo, A. PY - 2013 DA - 2013// TI - Pharmacogenetic analysis of SNPs in genes involved in the pharmacokinetics and response to lopinavir/ritonavir therapy JO - Curr Drug Metab VL - 14 UR - https://doi.org/10.2174/1389200211314070001 DO - 10.2174/1389200211314070001 ID - Lopez Aspiroz2013 ER - TY - JOUR AU - Xu, Y. AU - Wang, J. AU - Dong, W. PY - 2014 DA - 2014// TI - GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0083851 DO - 10.1371/journal.pone.0083851 ID - Xu2014 ER - TY - JOUR AU - Salinas-Souza, C. AU - Petrilli, A. S. AU - Toledo, S. R. PY - 2010 DA - 2010// TI - Glutathione S-transferase polymorphisms in osteosarcoma patients JO - Pharmacogenet Genomics VL - 20 UR - https://doi.org/10.1097/FPC.0b013e32833caa45 DO - 10.1097/FPC.0b013e32833caa45 ID - Salinas-Souza2010 ER - TY - JOUR AU - Jain, M. AU - Kumar, S. AU - Lal, P. AU - Tiwari, A. AU - Ghoshal, U. C. AU - Mittal, B. PY - 2007 DA - 2007// TI - Role of GSTM3 polymorphism in the risk of developing esophageal cancer JO - Cancer Epidemiol Biomarkers Prev VL - 16 UR - https://doi.org/10.1158/1055-9965.EPI-06-0542 DO - 10.1158/1055-9965.EPI-06-0542 ID - Jain2007 ER - TY - JOUR AU - Sener, E. F. AU - Taheri, S. AU - Korkmaz, K. AU - Zararsiz, G. AU - Serhatlioglu, F. AU - Unal, A. PY - 2014 DA - 2014// TI - Association of TNF-alpha −308 G > A and ACE I/D gene polymorphisms in hemodialysis patients with arteriovenous fistula thrombosis JO - Int Urol Nephrol VL - 46 UR - https://doi.org/10.1007/s11255-013-0580-2 DO - 10.1007/s11255-013-0580-2 ID - Sener2014 ER - TY - JOUR AU - Sun, Y. M. AU - Tian, Y. AU - Li, X. AU - Liu, Y. Y. AU - Wang, L. F. AU - Li, J. PY - 2009 DA - 2009// TI - Effect of atorvastatin on expression of IL-10 and TNF-alpha mRNA in myocardial ischemia-reperfusion injury in rats JO - Biochem Biophys Res Commun VL - 382 UR - https://doi.org/10.1016/j.bbrc.2009.03.019 DO - 10.1016/j.bbrc.2009.03.019 ID - Sun2009 ER - TY - JOUR AU - Kajinami, K. AU - Brousseau, M. E. AU - Ordovas, J. M. AU - Schaefer, E. J. PY - 2004 DA - 2004// TI - Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific manner JO - Am J Cardiol VL - 93 UR - https://doi.org/10.1016/j.amjcard.2004.01.014 DO - 10.1016/j.amjcard.2004.01.014 ID - Kajinami2004 ER - TY - JOUR AU - Hoenig, M. R. AU - Walker, P. J. AU - Gurnsey, C. AU - Beadle, K. AU - Johnson, L. PY - 2011 DA - 2011// TI - The C3435T polymorphism in ABCB1 influences atorvastatin efficacy and muscle symptoms in a high-risk vascular cohort JO - J Clin Lipidol VL - 5 UR - https://doi.org/10.1016/j.jacl.2011.01.001 DO - 10.1016/j.jacl.2011.01.001 ID - Hoenig2011 ER - TY - JOUR AU - Shabana, M. F. AU - Mishriki, A. A. AU - Issac, M. S. AU - Bakhoum, S. W. PY - 2013 DA - 2013// TI - Do MDR1 and SLCO1B1 polymorphisms influence the therapeutic response to atorvastatin? A study on a cohort of Egyptian patients with hypercholesterolemia JO - Mol Diagn Ther VL - 17 UR - https://doi.org/10.1007/s40291-013-0038-3 DO - 10.1007/s40291-013-0038-3 ID - Shabana2013 ER - TY - JOUR AU - Hoffmeyer, S. AU - Burk, O. AU - Richter, O. AU - Arnold, H. P. AU - Brockmoller, J. AU - Johne, A. PY - 2000 DA - 2000// TI - Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo JO - Proc Natl Acad Sci U S A VL - 97 UR - https://doi.org/10.1073/pnas.97.7.3473 DO - 10.1073/pnas.97.7.3473 ID - Hoffmeyer2000 ER - TY - JOUR AU - Wessler, J. D. AU - Grip, L. T. AU - Mendell, J. AU - Giugliano, R. P. PY - 2013 DA - 2013// TI - The P-glycoprotein transport system and cardiovascular drugs JO - J Am Coll Cardiol VL - 61 UR - https://doi.org/10.1016/j.jacc.2013.02.058 DO - 10.1016/j.jacc.2013.02.058 ID - Wessler2013 ER - TY - JOUR AU - Zhou, Q. AU - Ruan, Z. R. AU - Yuan, H. AU - Zeng, S. PY - 2012 DA - 2012// TI - CYP2C9*3(1075A > C), MDR1 G2677T/A and MDR1 C3435T are determinants of inter-subject variability in fluvastatin pharmacokinetics in healthy Chinese volunteers JO - Arzneimittelforschung VL - 62 UR - https://doi.org/10.1055/s-0032-1323696 DO - 10.1055/s-0032-1323696 ID - Zhou2012 ER - TY - JOUR AU - Gonzalez-Vacarezza, N. AU - Dorado, P. AU - Penas-Lledo, E. M. AU - Farinas, H. AU - Estevez-Carrizo, F. E. AU - Llerena, A. PY - 2013 DA - 2013// TI - MDR-1 genotypes and quetiapine pharmacokinetics in healthy volunteers JO - Drug Metabol Drug Interact VL - 28 UR - https://doi.org/10.1515/dmdi-2013-0008 DO - 10.1515/dmdi-2013-0008 ID - Gonzalez-Vacarezza2013 ER - TY - JOUR AU - Dong, Q. AU - Xu, B. AU - Tan, Y. AU - Liu, Z. AU - Tian, L. AU - Zhang, B. PY - 2009 DA - 2009// TI - The genetic variability of MDR1 C3435T polymorphisms in four Southern Chinese populations JO - Biomed Pharmacother VL - 63 UR - https://doi.org/10.1016/j.biopha.2008.09.003 DO - 10.1016/j.biopha.2008.09.003 ID - Dong2009 ER - TY - JOUR AU - Becker, M. L. AU - Visser, L. E. AU - Schaik, R. H. AU - Hofman, A. AU - Uitterlinden, A. G. AU - Stricker, B. H. PY - 2010 DA - 2010// TI - Influence of genetic variation in CYP3A4 and ABCB1 on dose decrease or switching during simvastatin and atorvastatin therapy JO - Pharmacoepidemiol Drug Saf VL - 19 UR - https://doi.org/10.1002/pds.1866 DO - 10.1002/pds.1866 ID - Becker2010 ER - TY - JOUR AU - Henningsson, A. AU - Marsh, S. AU - Loos, W. J. AU - Karlsson, M. O. AU - Garsa, A. AU - Mross, K. PY - 2005 DA - 2005// TI - Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-1152 DO - 10.1158/1078-0432.CCR-05-1152 ID - Henningsson2005 ER - TY - JOUR AU - Schaeffeler, E. AU - Eichelbaum, M. AU - Brinkmann, U. AU - Penger, A. AU - Asante-Poku, S. AU - Zanger, U. M. PY - 2001 DA - 2001// TI - Frequency of C3435T polymorphism of MDR1 gene in African people JO - Lancet VL - 358 UR - https://doi.org/10.1016/S0140-6736(01)05579-9 DO - 10.1016/S0140-6736(01)05579-9 ID - Schaeffeler2001 ER - TY - JOUR AU - Santos, P. C. AU - Gagliardi, A. C. AU - Miname, M. H. AU - Chacra, A. P. AU - Santos, R. D. AU - Krieger, J. E. PY - 2012 DA - 2012// TI - SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia JO - Eur J Clin Pharmacol VL - 68 UR - https://doi.org/10.1007/s00228-011-1125-1 DO - 10.1007/s00228-011-1125-1 ID - Santos2012 ER - TY - JOUR AU - Pasanen, M. K. AU - Fredrikson, H. AU - Neuvonen, P. J. AU - Niemi, M. PY - 2007 DA - 2007// TI - Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin JO - Clin Pharmacol Ther VL - 82 UR - https://doi.org/10.1038/sj.clpt.6100220 DO - 10.1038/sj.clpt.6100220 ID - Pasanen2007 ER -